2019 Novel Coronavirus Is Undergoing Active Recombination
Huiguang Yi
Clinical Infectious Diseases, doi:10.1093/cid/ciaa219
www. maths.otago.ac.nz/~dbryant/software/phimanual. pdf 9. Jiang X, Robertson DL. nCoV's relationship to bat coronaviruses and recombination signals (no snakes)-no evidence the 2019-nCoV lineage is recombinant. 2020.
References
Barnard, Day, Bailey, Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice, Antivir Chem Chemother
De Wilde, Jochmans, Posthuma, Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture, Antimicrob Agents Chemother
Savarino, Boelaert, Cassone, Majori, Cauda, Effects of chloroquine on viral infections: an old drug against today's diseases?, Lancet Infect Dis
Savarino, Boelaert, Cassone, Majori, Cauda, Effects of chloroquine on viral infections: an old drug against today's diseases?, Lancet Infect Dis
Schwartz, King, Protecting health care workers during the COVID-19 coronavirus outbreak: lessons from Taiwan's SARS response
Yao, Ye, Zhang, In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Yao, Ye, Zhang, In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Clin Infect Dis